Dissertation > Excellent graduate degree dissertation topics show

Efficacy of Donepezil for Vascular Dementia and the Dose Correlation:a Meta-analysis

Author: QuXiaoXia
Tutor: ZhouShengNian
School: Shandong University
Course: Clinical
Keywords: donepezil vascular dementia meta-analysis
CLC: R749.1
Type: Master's thesis
Year: 2012
Downloads: 100
Quote: 0
Read: Download Dissertation

Abstract


BackgroundVasculer dementia (VaD) is a syndrome caused by cerebrovascular lesions involving functionally important brain areas responsible for memory、cognition and behavior, which is the second most common type of dementia following AD. Along with global aging, the morbidity of VaD is rising. VaD seriously influenses the quality of the patients’life, and brings their families heavy burdens. It also brings a big challenge to the society. The cure of VaD is urgent. Therefore, people have turned their attention to effective medicine. A meta-analysis of several randomized controlled trials made by Richard A Hansen demonstrate that cholinesterase inhibitor(CHEI) is effective for mild and moderate Alzheimer’s disease(AD). Clinical evidence indicates that a cholinergic deficit, similar to that seen in AD, is associated with VaD, suggesting that patients with VaD may benefit from treatment with CHEI.The CHEI donepezil, is indicated for the treatment of AD, but if it can bring a benefit to patients with VaD still remains a dispute. There is considerable evidence regarding the efficacy of donepezil for patients with VaD. However, due to lack of sufficient evidence, there is still doubt about the answer. In the present study, we performed a meta-analysis to evaluate the efficacy of donepezil for the treatment of VaD and the dose correlation. ObjectiveTo evaluate the efficacy of donepezil for VaD and the dose correlation.MethodWe searched Pubmed、Cochrane Library、EMbase, using the terms "donepezil and vascular dementia", for relative randomized controlled trials. Information about age, sex, numbers randomized, design, medication doses, least squares mean change from baseline score, and adverse effect was extracted and a meta-analysis was performed by Revman5.1.4.0.ResultFour reports of randomized controlled trials were identified, involving2315patients with probable VaD or possible VaD. Of the2315patients,786were treated with placebo,399with donepezil5mg/day,1130with donepezil10mg/day. The ADAS-cog was used in all trials, which made it possible for our study. The result showed that both donepezil5mg/day(WMD-1.16,95%CI:-1.67—-0.65, P<0.00001) and10mg/day(WMD-2.17,95%CI:-2.97—-1.36. P<0.00001) significantly improved the patients’cognitive function, and there was no significant difference between the two doses(WMD-0.50,95%CI:-1.27—0.28, P=0.21).For functional and behavioral outcomes, only10mg/day donepezil group differed from placebo in functional assessment scores with a difference on the AD Functional Assessment and Change Scale(ADFACS, WMD-0.95,95%CI:-1.73—-0.17, P=0.02), and there was no significant difference between the two doses(WMD-0.21,95%CI:-0.98—0.57, P=0.60). Only5mg/day donepezil group differed from placebo on Mini-Mental State Examination (MMSE, WMD0.53,95%CI:0.18-0.89, P=0.003), and on Clinical Dementia Rating-Sum of Boxes score (CDR-SB), only10mg/day donepezil group differed from placebo(WMD-0.29,95%CI:-0.49—-0.09, P=0.005).ConclusionDonepezil provides small benefits for the treatment of patients’with mild to moderate VaD, and there is no difference in the efficacy between the two doses. Data is not sufficient for the present meta-analysis to support widespread use of donepezil in VaD.

Related Dissertations

  1. Methodology for Linkage-map-based Quantitative Trait Loci Synthesis Analysis,S562
  2. Heterogeneity and Meta Analysis of the Essential Hypertension Risk Assessments,R544.1
  3. Association of Interleukin-6 Gene Polymorphisms with Susceptibility to Coronary Heart Disease in Asian Populations: a Meta-analysis,R541.4
  4. Insight on Neuropsychological Characters between Different Kinds of Cognitive Impairment,R749.1
  5. Isoflavone intake and the risk of breast and prostate cancer Meta-analysis,R737.25
  6. ApoE genotype on donepezil hydrochloride treatment of elderly with mild cognitive impairment in,R749.1
  7. An Evidence-based Study on Risk Prediction of Alzheimer’s Disease,R749.16
  8. Meta Analysis of the Relationship between IL-6 or TNF-α and Human Primary Hepatocellular Carcinomas,R735.7
  9. Risk Factors of Cervical Cancer in Chinese and American Women: A Meta Analysis,R737.33
  10. MoCA in the diagnosis of vascular dementia Application of,R749.1
  11. Efficacy and Safety of mTOR Inhibitor for Early-stage ADPKD Patients: a Meta-analysis of Randomized Controlled Trials,R692.1
  12. Meta-analysis of Traditional Chinese Medicine Treatment on Migraine,R277.7
  13. Clinical Observation on Treatment of Vascular Dementia with Acupuncture Therapy,R246.6
  14. Yiqixingnao Particles Treatment VD of Qi Difficiency and Blood Stasis Clinical Observation,R277.7
  15. Health Risk Assessment and Exposure Standard Setup of Environmental Electromagnetic Fields,R14
  16. Protective Effects and Its Mechanisms of FLZ on Vascular Dementia in Rats,R96
  17. A Molecular Epidemiology Study on the Associations Between the MTHFR Polymorphisms and Genetic Susceptibility of Acute Lymphoblastic Leukemia,R733.7
  18. The Association Between the Genetic Variant in CHRNA3 Promoter and Risk of Lung Cancer in a Southern Chinese Population,R734.2
  19. Experimental Study of Tetramethylpyrazine Diphenylmethyl Piperazidine on Vascular Dementia Rats,R749.13
  20. Pump and off-pump coronary artery bypass grafting Meta-analysis of controlled studies,R654.2
  21. The Effects of Buyanghuanwu Decoction on the Glutamate Receptors in Hippocampal Neurons of Vascular Dementia Rats,R285.5

CLC: > Medicine, health > Neurology and psychiatry > Psychiatry > Cerebral organic mental disorder
© 2012 www.DissertationTopic.Net  Mobile